Abecma ema marketing authorisation date?

What date was Abecma’s marketing authorisation granted (EMA)?

Abecma (idecabtagene vicleucel) received its marketing authorisation from the European Medicines Agency (EMA) on 26 August 2020. [1]

When did Abecma first get EMA approval in the EU?

That 26 August 2020 date is the original EU marketing authorisation date for Abecma. [1]

Has the EMA authorisation date changed due to renewals or updates?

The EMA marketing authorisation date refers to when the product first received approval. Updates after approval can happen via later variation approvals or extensions, but they do not change the original marketing authorisation date. For Abecma, the stated authorisation date remains 26 August 2020. [1]

Sources

1. EMA – Abecma (idecabtagene vicleucel) EPAR page (marketing authorisation date: 26 August 2020)